Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Cancer is a complex group of diseases and is often caused by a combination of genetic, environmental, and lifestyle factors.

A new study shows that MXene-based nanozymes enhance cancer treatment by combining catalytic activity with electrical pulses, ...

Early-onset CRC (EO-CRC) was associated with Flavonifractor plautii and increased bile acid, tryptophan, and choline ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

The research team, led by Professor Tu Wenwei (second right) and Professor Wang Weiping (second left), has made a ...

The cancerous cells can lurk, sometimes for years ... Engineering Novel DNA Nanoarchitectures for Targeted Drug Delivery and ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells ...

This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.